By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid today announced that Labsco has been named a US distribution partner for its GeneXpert Systems and tests.

Labsco has exclusive US distribution rights to sell the Cepheid products to acute care hospitals with less than 150 beds. The deal does not include Cepheid's higher-throughput GeneXpert Infinity System, the Sunnyvale, Calif.-based molecular diagnostics firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.